Carolina Molecular

Carolina Molecular Inc. is a specialized molecular testing services provider operating a CAP-accredited, CLIA-certified laboratory. It offers a comprehensive suite of services including clinical diagnostics, NGS sequencing, spatial profiling, single-cell analysis, and custom bioinformatics, primarily serving CROs, CDMOs, cell and gene therapy innovators, and research institutions. The company differentiates itself through its accredited clinical lab expertise, strategic technology partnerships (e.g., Illumina, Element Biosciences, NanoString), and a hassle-free service model with transparent pricing and dedicated project management. Its focus areas are oncology, infectious disease, and immunology, supporting clinical trials, diagnostic development, and discovery research.

Multi-vendor technology stack for molecular testing, including Illumina NGS (NovaSeq, NextSeq, MiSeq), Element Biosciences AVITI sequencing, NanoString GeoMx Spatial Profiling, 10x Genomics single-cell RNAseq, Luminex protein analysis, and Sanger sequencing. Supported by custom bioinformatics pipelines.

Competes with large national clinical labs (Quest Diagnostics, LabCorp), specialized genomic service providers (e.g., Psomagen, Azenta Life Sciences), and academic core facilities. Differentiation is based on niche clinical expertise, a multi-platform technology offering, and a high-touch, hassle-free service model for biopharma and CRO partners.